How to test for type 2 diabetes and colon cancer

JP7740733B2Active Publication Date: 2025-09-17OSAKA UNIVERSITY
View PDF 11 Cites 0 Cited by

Patent Information

Application Number
JP2023545119
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2021-08-31
Filing Date
2022-06-30
Publication Date
2025-09-17
Estimated Expiration
2042-06-30
Patent Text Reader

Abstract

The present invention provides a new biomarker for type-2 diabetes and colon cancer, and a usage method thereof. This test method is for at least one target disease selected from the group consisting of type-2 diabetes and colon cancer, the test method comprising (1) a step for detecting miR-1908-5p in a body fluid collected from a subject.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Serum miRNA biomarker of type 2 diabetes mellitus and application thereof

    CN103555724A

  • miRNA associated with colorectal cancer and application thereof

    CN105624271A

  • Serum or plasma miRNA marker related to diabetes mellitus type 2 and application thereof

    CN106148537A

  • MiRNA molecule marker hsa-miR-152-3p for diagnosing type 2 diabetes, and application thereof

    CN106434872A

  • MiR-145-5P molecular marker for detecting type 2 diabetes mellitus, and amplification primers and application of miR-145-5P molecular marker

    CN110791562A